Genentech's website: note section on serious side effects
Monday, March 01, 2010
Subscribe to:
Post Comments (Atom)
Google Search: this blog, links from posts and the web....
Special items:
- ADD YOUR OPINIONS: ovarian cancer, genetics, access to care.....
- POST YOUR OC EVENTS
- Clinical Trials
- video clips: Survivors' Debate: The Past Decade in Ovarian Cancer
- Special Ovarian Cancer Womens Montage
- Video - Ovarian Cancer and Our Pets
- BSB4uD (Be Smart Before You Donate)
- for fun - cat walks owner (2 x youtube)
Ovarian Cancer and Us - Google+
Follow by Email
newsreel: click each header to view news
Flash Headlines
Recent Comments
Subscribe To Ovarian Cancer and Us blog
Posts
Comments
Share blog:
subscribe: Google Reader
Ovarian Cancer: The Past Decade - conference(s) & post analysis in brief:
Sandi Pniauskas Ovarian Cancer and Us
Read This:
SURVIVORS' DEBATE: The Past Decade in Ovarian Cancer (blog)
SURVIVORS' DEBATE: The Past Decade in Ovarian Cancer
Signs and Symptoms of Ovarian Cancer plus Genetics (professional vs consumer concensus/survey):
Blog Archive
-
►
2012
(1046)
-
►
March
(26)
-
►
Mar 02
(11)
- FDA U.S. Drug Shortages - Paclitaxel (Taxol)
- The silent minority - unpublished data on cancer c...
- 2012 Hormone Therapy Position Statement of the Nor...
- FDA: The Quality Problems Causing The Drug Shortag...
- [Comment] Offline: Is CDC a science-based organisa...
- media: Benefits of Bevacizumab in Ovarian Cancer C...
- [Lancet Oncology News] US firm corners exclusive l...
- High-Risk Ovarian Cancer Based on 126-Gene Express...
- Phase I Study of the Vascular-Disrupting Agent OXi...
- abstract: Histology-specific long-term trends in t...
- Bioinformatics and epigenetics - computer-aided ca...
-
►
Mar 01
(15)
- The Royal College of Physicians of London roars : ...
- abstract: Serum HE4 as a diagnostic and prognostic...
- abstract: Role of Neoadjuvant Chemotherapy in the ...
- abstract: Unopposed estrogen and estrogen plus pro...
- Cancer misdiagnosis claim refuted (From The Oxford...
- still recruiting: A (phase 11) Study of MK-1775 in...
- Comment on Keeping Up With Science : InTech Publis...
- PCORI Paddles the Potomac (healthcare systems/dys...
- Correspondence: Emergency Hospitalizations for Adv...
- open access - 4 articles: Shared Decision Making —...
- open access: Shared Decision Making — The Pinnacle...
- open access: Goal-Oriented Patient Care — An Alter...
- A phase II trial (AGO 2.11) in platinum-resistant ...
- Risk of serious toxicity in 1181 patients treated ...
- Grants.gov - Opportunity Synopsis - OCRP Ovarian C...
-
►
Mar 02
(11)
-
►
February
(503)
-
►
Feb 29
(19)
- American Institute for Cancer Research (AICR): 201...
- Clinical Oncology News - Study Details Risks for C...
- Clinical Oncology News - Applying Clinical Trial R...
- The POWER Study (Project for an Ontario Women's He...
- Canadian Scientists Develops World’s Most Advanced...
- abstract: Borderline ovarian tumour: pathological ...
- abstract: Inflammatory Pseudotumor: The Great Mimi...
- ( Italy) Hyperthermic Intra-peritoneal Chemotherap...
- not yet recruiting: phase 11/BRCA - Veliparib in T...
- Tutorials (2): Genetic Testing Registry (GTR) - Yo...
- Confused by genetic tests? NIH's new online tool m...
- Stopping menopausal hormone therapy: If breast can...
- abstract : Hazard ratios in cancer clinical trials...
- Advanced Ovarian Cancer -- A Clinical Context Repo...
- open access: PLoS ONE: Standard Colonic Lavage Alt...
- abstract: Priorities for cancer prevention: lifest...
- abstract: Radiation Oncology Quality: Aggressivene...
- abstManagement-changing errors in the recall of ra...
- Neoadjuvant chemotherapy, interval debulking surge...
-
►
Feb 29
(19)
-
►
March
(26)
- ► 2011 (1378)
- ► 2009 (1448)
BlogCatalog
of interest:
Atom
0 comments:
Post a Comment